30
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Rotamase inhibitors for neurological diseases

Pages 1613-1616 | Published online: 25 Feb 2005
 

Abstract

Following the observation that the macrolide FK506 is a potent promoter of neurite growth in vitro and in vivo, this activity was shown to depend on inhibition of cis-trans peptidyl prolyl isomerase (rotamase) activity in FK506 binding proteins. Rotamase inhibitors may therefore be of clinical use in various nervous system disorders as promoters of neurite growth. This article reviews five recent patents claiming novel rotamase inhibitors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.